Todd A Wyatt Selected Research

Infections

2/2022	SARS-CoV-2 Dysregulates Neutrophil Degranulation and Reduces Lymphocyte Counts.
7/2021	Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.
1/2021	Second hits exacerbate alcohol-related organ damage: an update.
1/2017	Alcohol drives S-nitrosylation and redox activation of protein phosphatase 1, causing bovine airway cilia dysfunction.
1/2015	Exercise Improves Host Response to Influenza Viral Infection in Obese and Non-Obese Mice through Different Mechanisms.
8/2007	Association of chronic alcohol consumption and increased susceptibility to and pathogenic effects of pulmonary infection with respiratory syncytial virus in mice.
4/2007	Effects of cigarette smoke and alcohol on ciliated tracheal epithelium and inflammatory cell recruitment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Todd A Wyatt Research Topics

Disease

25	Inflammation (Inflammations) 11/2021 - 05/2005
11	Pneumonia (Pneumonitis) 06/2022 - 05/2005
10	Lung Diseases (Lung Disease) 06/2022 - 05/2008
9	Wounds and Injuries (Trauma) 01/2022 - 05/2002
7	Infections 02/2022 - 04/2007
6	Alcoholism (Alcohol Abuse) 01/2022 - 05/2005
6	Lung Injury 01/2022 - 02/2012
5	Asthma (Bronchial Asthma) 07/2021 - 01/2005
4	Respiratory Syncytial Virus Infections 07/2021 - 01/2016
4	Chronic Obstructive Pulmonary Disease (COPD) 07/2020 - 01/2005
4	Respiratory Hypersensitivity 03/2019 - 06/2009
3	Experimental Arthritis 06/2022 - 01/2021
3	Chronic Bronchitis 09/2018 - 01/2005
2	Rheumatoid Arthritis 06/2022 - 11/2021
2	Fibrosis (Cirrhosis) 01/2022 - 02/2002
2	Arthritis (Polyarthritis) 11/2021 - 01/2021
2	Obesity 01/2015 - 05/2005
2	Hyperplasia 12/2010 - 01/2008
2	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 03/2009 - 02/2008
1	Chronic Pancreatitis 10/2022
1	Pancreatitis 10/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Adenocarcinoma 12/2021
1	COVID-19 11/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 11/2021
1	Virus Diseases (Viral Diseases) 07/2021
1	Metaplasia 07/2021
1	Bacterial Pneumonia 01/2021
1	Chronic Disease (Chronic Diseases) 01/2021
1	Chronic Cough 09/2018
1	Obstructive Lung Diseases (Obstructive Lung Disease) 07/2015
1	Liver Diseases (Liver Disease) 01/2015
1	Burns 01/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2015
1	Human Influenza (Influenza) 01/2015

Drug/Important Bio-Agent (IBA)

16	SmokeIBA 01/2022 - 05/2005
9	Proteins (Proteins, Gene)FDA Link 10/2022 - 05/2005
8	Ethanol (Ethyl Alcohol)IBA 11/2019 - 04/2005
7	AcetaldehydeIBA 10/2022 - 05/2005
7	Malondialdehyde (Propanedial)IBA 10/2022 - 05/2005
7	CytokinesIBA 07/2021 - 01/2005
6	Protein Kinase CIBA 01/2022 - 05/2005
4	AldehydesIBA 10/2022 - 11/2015
4	Methacholine Chloride (Methacholine)FDA Link 03/2019 - 06/2009
4	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2018 - 05/2002
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016 - 01/2005
3	ZincIBA 01/2022 - 01/2019
3	Interleukin-33IBA 11/2021 - 07/2021
3	Adenosine (Adenocard)FDA LinkGeneric 01/2017 - 05/2002
3	Toll-Like Receptor 2IBA 10/2011 - 03/2009
2	AutoantigensIBA 06/2022 - 11/2021
2	Small Interfering RNA (siRNA)IBA 01/2022 - 10/2021
2	Protein Kinase C-epsilonIBA 01/2022 - 10/2012
2	EndotoxinsIBA 11/2021 - 01/2005
2	Hazardous Substances (Hazardous Materials)IBA 11/2021 - 01/2021
2	Immunoglobulin A (IgA)IBA 10/2021 - 12/2017
2	Messenger RNA (mRNA)IBA 07/2021 - 08/2007
2	OvalbuminIBA 07/2021 - 03/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 05/2013
2	InterferonsIBA 01/2021 - 08/2007
2	ChemokinesIBA 11/2019 - 01/2015
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 11/2019 - 01/2017
2	AerosolsIBA 09/2018 - 08/2007
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2017 - 05/2005
2	Interleukin-6 (Interleukin 6)IBA 02/2016 - 07/2015
2	Interleukin-8 (Interleukin 8)IBA 02/2016 - 10/2014
1	Extracellular Matrix ProteinsIBA 10/2022
1	HLA-DR4 Antigen (HLA DR4 Antigen)IBA 06/2022
1	Pancreatic Elastase (Elastase)IBA 02/2022
1	reproxalapIBA 01/2022
1	perflubron (L 1913)FDA Link 01/2022
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022
1	FluorocarbonsIBA 01/2022
1	Chemokine ReceptorsIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 12/2021
1	NF-kappa B (NF-kB)IBA 12/2021
1	IsotopesIBA 12/2021
1	Air Pollutants (Pollutants, Air)IBA 11/2021
1	salicylhydroxamic acid (SHAM)IBA 11/2021
1	LipopolysaccharidesIBA 11/2021
1	Thymic Stromal LymphopoietinIBA 07/2021
1	Interleukin-23 (Interleukin 23)IBA 07/2021
1	zinc-binding protein (zinc binding protein)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	CadmiumIBA 07/2020
1	Interleukin-10 (Interleukin 10)IBA 09/2018
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2018
1	dimethylargininaseIBA 01/2018
1	AntibodiesIBA 12/2017
1	Surface-Active Agents (Surfactants)IBA 01/2017
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	DNA AdductsIBA 11/2015
1	Peptide Hydrolases (Proteases)FDA Link 08/2015
1	Arginine (L-Arginine)FDA Link 07/2015
1	Chemokine CXCL1IBA 07/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 07/2015
1	Vitamin D FDA LinkGeneric 05/2015
1	Peptides (Polypeptides)IBA 01/2015

Therapy/Procedure

3	Therapeutics 10/2021 - 07/2015